You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Colorcon
Boehringer Ingelheim
McKinsey
Baxter

Last Updated: March 30, 2020

DrugPatentWatch Database Preview

Litigation Details for Biovail Lab Inc v. Apotex Inc (N.D. Ill. 2001)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Biovail Lab Inc v. Apotex Inc (N.D. Ill. 2001)

Docket   Start Trial Date Filed 2001-11-21
Court District Court, N.D. Illinois Date Terminated 2005-03-01
Cause 35:271 Patent Infringement Assigned To Wayne R. Andersen
Jury Demand None Referred To
Parties BIOVAIL LABORATORIES, INC.; TORPHRAM, INC.; TWFC, INC.
Patents 5,286,497; 5,439,689; 5,470,584
Attorneys Alan H. Bernstein; Allan T. Slagel; Charles A. Laff; Charles R. Krikorian; Douglas Michael Ramsey; Eric Charles Cohen; Howard Langer; James Patrick White; Jason Eric Pepe; John B. Grogan; John J Gorgan; Joseph Eben Cwik; Joseph M Rebein; Kevin Charles Trock; Lynn M. Terrebonne; Manotti L Jenkins; Michael J Berkowitz; Michael Keenan Nutter; Robert B. Breisblatt; Robert S Silver; Sean Steven Swidler; William J Castillo
Firms Caesar, Rivise, Bernstein, Cohen & Pokotilow, LTD; Caesar, Rivise, Bernstein, Cohen, & Pokotilow, Ltd.; Caesar, Rivise, Bernstein, Et Al.; Husch Blackwell Sanders LLP; John B. Grogan, Ltd.; Katten Muchin Rosenman LLP; Katten Muchin Zavis Rosenman; Langer & Grogan P.C.; Michael Best & Fredrich LLC; Patzik, Frank & Samotny, Ltd.; Shefsky & Froelich Ltd; Shook, Hardy & Bacon; Welsh & Katz, Ltd.; Winston and Strawn LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Biovail Lab Inc v. Apotex Inc
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Biovail Lab Inc v. Apotex Inc (N.D. Ill. 2001)

Date Filed Document No. Description Snippet Link To Document
2001-11-21 1 United States patents in the Orange Book as covering CARDIZEM® CDTM: U.S. Patent Nos. 5,286,497, 5,439,689… the United States. 8. U.S. Patent No. 5,286,497 (“the ‘49'7 patent) was duly and legally issued …and TWFC, Inc. for infringement of U.S. Patents Nos. 5,286,497, 5,439,689, and 5,470,584 under 35 U.S.…has infringed one or more of valid U.S. Patent Nos. 5,286,497, 5,439,689, and 5,470,584 under 35 U.S.C…earlier than the last expiration of U.S. Patent Nos. 5,286,497, 5,439,689, or 5,470,584; For an award External link to document
2004-07-12 147 claims and counterclaims of United States Patent Nos. 5,286,497 and 5,439,689 are hereby dismissed without…2001 1 March 2005 1:01-cv-09008 830 Patent None District Court, N.D. Illinois External link to document
2004-11-22 183 ] of non-infringement of claim 1 of U.S. Patent No. 5,470,584. (RESTRICTED). (gcy) (Entered: 12/02/2004…2001 1 March 2005 1:01-cv-09008 830 Patent None District Court, N.D. Illinois External link to document
2005-01-07 197 judgment of non-infringement of claim 1 of U.S. Patent No. 5,470,584. (RESTRICTED). (gcy) (Entered: 01/10/2005…2001 1 March 2005 1:01-cv-09008 830 Patent None District Court, N.D. Illinois External link to document
2005-01-07 198 judgment of non-infringement of claim 1 of U.S. Patent No. 5,470,584. (RESTRICTED). (gcy) (Entered: 01/10/2005…2001 1 March 2005 1:01-cv-09008 830 Patent None District Court, N.D. Illinois External link to document
2005-01-21 201 summary judgment of non-infringement of U.S. Patent No. 5,470,584. (RESTRICTED). (gcy, ) (Entered: 01/24/2005…2001 1 March 2005 1:01-cv-09008 830 Patent None District Court, N.D. Illinois External link to document
2002-07-23 40 respectively oi`U.S. Patettt Nos. 5,286,497, 5,439,689, and 5,470,584. These patents cover the heart drug diltiazetn…claimed in a patent or the use of Which is claimed in a patent before the expiration of such a patent."… not raise the issue of patent invalidity; instead it argues that the patents were not infringed In addition…Ccrtiftcation stating that it believed that the three patents in suit Would not be infringedl S_e_e 21 U.S.C.…plaintiffs filed the present lawsuit under the Patent infringement Act, 35 U.S.C. § 271, et seq. Section External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
McKinsey
Express Scripts
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.